[225Ac]Ac-PSMA-617 Targeted Alpha Therapy in Metastatic Castration-Resistant Prostate Cancer: efficacy and treatment outcome

被引:0
|
作者
Ebrahimifard, A. [1 ]
Bagheri, S. [1 ]
Wang, Q. [1 ]
Eilsberger, F. [1 ]
Luster, M. [1 ]
Librizzi, D. [1 ]
Yousefi, B. H. [1 ]
机构
[1] Philipps Univ Marburg, Marburg, Germany
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OP-760
引用
收藏
页码:S360 / S360
页数:1
相关论文
共 50 条
  • [21] Re: 225Ac-PSMA-617 for PSMA-Targeting Alpha-radiation Therapy of Patients with Metastatic Castration-resistant Prostate Cancer
    Hadaschik, Boris
    EUROPEAN UROLOGY, 2016, 70 (06) : 1080 - 1081
  • [22] 225Ac-PSMA-617/177Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer: pilot experience
    Fadi Khreish
    Niklas Ebert
    Martin Ries
    Stephan Maus
    Florian Rosar
    Hendrik Bohnenberger
    Tobias Stemler
    Matthias Saar
    Mark Bartholomä
    Samer Ezziddin
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 721 - 728
  • [23] 225Ac-PSMA-617/177Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer: pilot experience
    Khreish, Fadi
    Ebert, Niklas
    Ries, Martin
    Maus, Stephan
    Rosar, Florian
    Bohnenberger, Hendrik
    Stemler, Tobias
    Saar, Matthias
    Bartholomae, Mark
    Ezziddin, Samer
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (03) : 721 - 728
  • [24] Treatment of Multiple Bone Metastases of Castration-Resistant Prostate Cancer With 225Ac-PSMA-617
    Yang, Hongyu
    Zhang, Yu
    Su, Dan
    Chen, Yue
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (12) : 1078 - 1081
  • [25] 225Ac-PSMA-617 targeted alpha therapy after Docetaxel based chemotherapy in the patients of metastatic castration resistant prostate cancer
    Sen, Ishita
    Pant, Vineet
    Thakral, Parul
    Raina, Vinod
    Das, Subha
    Sharma, Kanchan
    Manda, Divya
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [26] Radiolabeling of [225Ac]Ac-PSMA-617 vs [225Ac]Ac-DOTATATE: What Analogies? What Differences?
    Esposito, A.
    Aurilio, M.
    Buonanno, M.
    Morisco, A.
    Maisto, C.
    D'Ambrosio, L.
    Di Martino, D.
    Lastoria, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S782 - S783
  • [27] Simple method for production and quality control of 225Ac- PSMA-617 for the targeted alpha therapy of castration-resistant prostate cancer.
    Khoshhosn, H.
    Dayeni, M.
    Pirdadeh, M.
    Ghapanvari, M.
    Tavakoli, Y.
    Samizadeh, M.
    Mazidi, M.
    Nami, R.
    Soltani, N.
    Movahhed, H.
    Gravand, A.
    Sarabi, A.
    Davarpanah, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S674 - S675
  • [28] Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617:Swimmer-Plot Analysis Suggests Efficacy Regarding Duration of Tumor Control
    Kratochwil, Clemens
    Bruchertseifer, Frank
    Rathke, Hendrik
    Hohenfellner, Markus
    Giesel, Frederik L.
    Haberkorn, Uwe
    Morgenstern, Alfred
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (05) : 795 - 802
  • [29] Advances in 177Lu-PSMA and 225Ac-PSMA Radionuclide Therapy for Metastatic Castration-Resistant Prostate Cancer
    Ling, Sui Wai
    de Blois, Erik
    Hooijman, Eline
    van der Veldt, Astrid
    Brabander, Tessa
    PHARMACEUTICS, 2022, 14 (10)
  • [30] Clinical-Prostate cancer Clinical outcomes and molecular profiling of advanced metastatic castration-resistant prostate cancer patients treated with 225Ac-PSMA-617 targeted alpha-radiation therapy
    van der Doelen, Maarten J.
    Mehra, Niven
    van Oort, Inge M.
    Looijen-Salamon, Monika G.
    Janssen, Marcel J. R.
    Custers, Jose A. E.
    Slootbeek, Peter H. J.
    Kroeze, Leonie, I
    Bruchertseifer, Frank
    Morgenstern, Alfred
    Haberkorn, Uwe
    Kratochwil, Clemens
    Nagarajah, James
    Gerritsen, Winald R.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (10) : 729.e7 - 729.e16